研究建议根据昼夜节律对三阴性乳腺癌药物5-FU的时间进行调整,以改善结果. Study suggests timing triple-negative breast cancer drug 5-FU administration based on circadian rhythm for improved outcomes.
柏林Charite-Universitatsmedizin的一项研究表明,根据病人的心律节奏进行癌症治疗的计时治疗可能会对治疗结果产生重大影响。 A study from Charite-Universitatsmedizin Berlin suggests that timing cancer medication administration based on a patient's circadian rhythm could significantly impact treatment outcomes. 研究人员发现,三阴性乳腺癌细胞在上午8时至10时最能对5-FU乳胶酸性药物产生反应。 他们的研究结果可以为个人化的癌症治疗铺平道路,这种治疗以个体环形节奏为基础。 The researchers identified that triple-negative breast cancer cells are most responsive to chemotherapeutic drug 5-FU between 8 and 10 a.m. Their findings could pave the way for personalized cancer treatments based on individual circadian rhythms. 需要进行更多的研究,以验证研究结果。 More research is needed to validate the study results.